Diabetes Control Has Stalled Across U.S.
FRIDAY, Sept. 6, 2019 -- U.S. adults with diabetes are no more likely to meet disease control targets than they were in 2005, a new study finds.
Typically, diabetes treatment focuses on controlling blood sugar, blood pressure and cholesterol levels, as well as not smoking.
For the study, Massachusetts General Hospital researchers analyzed data on diabetes care in the United States from 2005 through 2016. The investigators found that one in four adults with diabetes was not diagnosed, and nearly one in three was not receiving appropriate care for diabetes.
"Fewer than one in four American adults with diagnosed diabetes achieve a controlled level of blood sugar, blood pressure and cholesterol and do not smoke tobacco," said study lead author Pooyan Kazemian, of the hospital's Medical Practice Evaluation Center.
"Our results suggest that, despite major advances in diabetes drug discovery and movement to develop innovative care delivery models over the past two decades, achievement of diabetes care targets has not improved in the United States since 2005," Kazemian said in a hospital news release.
More than 30 million Americans have diabetes. Most have type 2, which is linked to lifestyle.
Certain groups of patients were less likely to achieve diabetes care targets, according to the study.
"Younger age (18-44), female and nonwhite adults with diabetes had lower odds of achieving the composite blood sugar, blood pressure, cholesterol and nonsmoking target," Kazemian said.
Patients with insurance coverage were most likely to have been diagnosed with diabetes and to have achieved treatment targets, the researchers noted.
According to study senior author Dr. Deborah Wexler, "Barriers accessing health care, including lack of health insurance and high drug costs, remain major factors that have not been adequately addressed on a population level." Wexler is with the hospital's diabetes unit and is an instructor in medicine at Harvard Medical School.
"Treatment advances in diabetes mellitus can meaningfully improve outcomes only if they effectively reach the populations at risk. Our findings suggest this is not the case in the U.S.," Wexler said.
The findings, she added, indicate an immediate need for better approaches to diabetes care delivery, "including a continued focus on reaching underserved populations with persistent disparities in care."
The study was published online recently in JAMA Internal Medicine.
© 2020 HealthDay. All rights reserved.
Posted: September 2019
Read this next
THURSDAY, Oct. 22, 2020 -- If you've got type 2 diabetes and love drinking green tea or coffee, new research suggests you may be reducing your odds of a premature death. But you...
WEDNESDAY, Oct. 21, 2020 -- Scientists knew that dangerous T-cells lived in the pancreases of people with type 1 diabetes, but a new study shows they also take up residence in the...
TUESDAY, Oct. 13, 2020 -- A small study suggests that a new procedure that treats part of the intestine just beyond the stomach may allow people with type 2 diabetes to safely...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.